Company / Gross Margin
TELA Bio, Inc. Gross Margin History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
68.6%
FY2025
5-year range
60.0% / 68.6%
FY2021-FY2025
Trend
+5.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Margin has increased for 5 consecutive years, from 35.6% in FY2020 to 68.6% in FY2025.
Based on SEC 10-K filings.
68.6% in FY2025 with a 5-year CAGR of +33.1%.
Improved from 63.8% to 68.6% over the past 2 years.
Gross Margin over time
Growth rates
- 3-Year Change
- +6.9pp
- 5-Year Change
- +33.1pp
- 10-Year Change
- -
Key checks
Key Insights
- TELA Bio, Inc.'s gross margin has grown for 5 consecutive years.
- In FY2025, gross margin increased 5.1% year-over-year.
- Lowest gross margin in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -0.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 68.6% | +5.1% |
| FY2024 | 65.3% | +2.3% |
| FY2023 | 63.8% | +3.5% |
| FY2022 | 61.7% | +2.7% |
| FY2021 | 60.0% | +68.8% |
| FY2020 | 35.6% | -40.4% |
| FY2019 | 59.7% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026